pralatraxate,: Clinical Trials

1 trial of pralatraxate,, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Recruiting 1

Follow pralatraxate,: new trials by email Literature Review of pralatraxate, trials Research Report on pralatraxate,

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
Methotrexate, pralatraxate,, Ifosfamide - NK-Cell Lymphoma, NK-Cell Leukemia
Early Phase 1RecruitingNew York Medical College402019-03-012026-08-18

Conditions studied

Leukemia, Large Granular Lymphocytic (1)  ·  Lymphoma, T-Cell, Peripheral (1)

Sponsors

New York Medical College (1)

Countries

United States (1)

Top investigators

Mitchell Cairo, MD (1)